These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 25813210)

  • 1. GPX2 underexpression indicates poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder.
    Chang IW; Lin VC; Hung CH; Wang HP; Lin YY; Wu WJ; Huang CN; Li CC; Li WM; Wu JY; Li CF
    World J Urol; 2015 Nov; 33(11):1777-89. PubMed ID: 25813210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HAS3 underexpression as an indicator of poor prognosis in patients with urothelial carcinoma of the upper urinary tract and urinary bladder.
    Chang IW; Liang PI; Li CC; Wu WJ; Huang CN; Lin VC; Hsu CT; He HL; Wu TF; Hung CH; Li CF
    Tumour Biol; 2015 Jul; 36(7):5441-50. PubMed ID: 25934334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCAT1 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder.
    Chang IW; Wu WJ; Wang YH; Wu TF; Liang PI; He HL; Yeh BW; Li CF
    Histopathology; 2016 Mar; 68(4):520-32. PubMed ID: 26173071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract.
    Lee HY; Li CC; Huang CN; Li WM; Yeh HC; Ke HL; Yang KF; Liang PI; Li CF; Wu WJ
    J Surg Oncol; 2015 Mar; 111(4):414-22. PubMed ID: 25488476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MCM10 overexpression implicates adverse prognosis in urothelial carcinoma.
    Li WM; Huang CN; Ke HL; Li CC; Wei YC; Yeh HC; Chang LL; Huang CH; Liang PI; Yeh BW; Chan TC; Li CF; Wu WJ
    Oncotarget; 2016 Nov; 7(47):77777-77792. PubMed ID: 27780919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase-11 as a marker of metastasis and predictor of poor survival in urothelial carcinomas.
    Li WM; Wei YC; Huang CN; Ke HL; Li CC; Yeh HC; Chang LL; Huang CH; Li CF; Wu WJ
    J Surg Oncol; 2016 May; 113(6):700-7. PubMed ID: 26861489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tract.
    Lee HY; Yeh BW; Chan TC; Yang KF; Li WM; Huang CN; Ke HL; Li CC; Yeh HC; Liang PI; Shiue YL; Wu WJ; Li CF
    Oncotarget; 2017 Jul; 8(29):47216-47229. PubMed ID: 28525382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder.
    Liang PI; Wang YH; Wu TF; Wu WR; Liao AC; Shen KH; Hsing CH; Shiue YL; Huang HY; Hsu HP; Chen LT; Lin CY; Tai C; Wu JY; Li CF
    J Clin Pathol; 2013 Jul; 66(7):573-82. PubMed ID: 23539739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF7 Over Expression is an Independent Prognosticator in Patients with Urothelial Carcinoma of the Upper Urinary Tract and Bladder.
    Fan EW; Li CC; Wu WJ; Huang CN; Li WM; Ke HL; Yeh HC; Wu TF; Liang PI; Ma LJ; Li CF
    J Urol; 2015 Jul; 194(1):223-9. PubMed ID: 25623741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder.
    Lee YE; Chan TC; Tian YF; Liang PI; Shiue YL; Chen YS; He HL
    Urol Oncol; 2019 May; 37(5):299.e7-299.e18. PubMed ID: 30660494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of the cytochrome P450 4B1 protein confers a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder.
    Lin JT; Chan TC; Li CF; Huan SKH; Tian YF; Liang PI; Pan CT; Shiue YL
    APMIS; 2019 Apr; 127(4):170-180. PubMed ID: 30803053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necdin Overexpression Predicts Poor Prognosis in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder.
    Chang IW; Wang YH; Wu WJ; Liang PI; Li WM; Yeh BW; Wu TF; He HL; Huang SK; Li CF
    J Cancer; 2016; 7(3):304-13. PubMed ID: 26918044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTP4A3 Independently Predicts Metastasis and Survival in Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy.
    Yeh HC; Li CC; Huang CN; Hour TC; Yeh BW; Li WM; Liang PI; Chang LL; Li CF; Wu WJ
    J Urol; 2015 Nov; 194(5):1449-55. PubMed ID: 26070892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF2 Overexpression Is Associated with STAT5 Phosphorylation and Poor Prognosis in Patients with Urothelial Carcinoma.
    Lee YY; Wu WJ; Huang CN; Li CC; Li WM; Yeh BW; Liang PI; Wu TF; Li CF
    J Cancer; 2016; 7(6):711-21. PubMed ID: 27076853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDCA5 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder.
    Chang IW; Lin VC; He HL; Hsu CT; Li CC; Wu WJ; Huang CN; Wu TF; Li CF
    Am J Transl Res; 2015; 7(4):710-22. PubMed ID: 26064439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPOCK1 Overexpression Confers a Poor Prognosis in Urothelial Carcinoma.
    Ma LJ; Wu WJ; Wang YH; Wu TF; Liang PI; Chang IW; He HL; Li CF
    J Cancer; 2016; 7(4):467-76. PubMed ID: 26918061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of upper urinary tract and urinary bladder.
    He HL; Lai HY; Chan TC; Hsing CH; Huang SK; Hsieh KL; Chen TJ; Li WS; Kuo YH; Shiue YL; Li CF
    World J Surg Oncol; 2023 Feb; 21(1):62. PubMed ID: 36841776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of p21-activated kinase 1 expression level in patients with upper urinary tract urothelial carcinoma.
    Kuroda K; Asakuma J; Asano T; Horiguchi A; Isono M; Tsujita Y; Sato A; Seguchi K; Ito K; Asano T
    Jpn J Clin Oncol; 2015 Jan; 45(1):103-10. PubMed ID: 25324479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of RNF128 Predicts Progression and Poor Prognosis in Patients with Urothelial Carcinoma of the Upper Tract and Urinary Bladder.
    Lee YY; Wang CT; Huang SK; Wu WJ; Huang CN; Li CC; Chan TC; Liang PI; Hsing CH; Li CF
    J Cancer; 2016; 7(15):2187-2196. PubMed ID: 27994654
    [No Abstract]   [Full Text] [Related]  

  • 20. DDR2 overexpression in urothelial carcinoma indicates an unfavorable prognosis: a large cohort study.
    Tsai MC; Li WM; Huang CN; Ke HL; Li CC; Yeh HC; Chan TC; Liang PI; Yeh BW; Wu WJ; Lim SW; Li CF
    Oncotarget; 2016 Nov; 7(48):78918-78931. PubMed ID: 27793038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.